Posted On: 12/13/2013 12:37:37 PM
Post# of 29851
$ VGLS - completed the Phase I Study for tolerability and toxicity of its patented technology in patients with advanced stage solid tumors . The disease stabilization in a patient with metastatic ovarian cancer for 4 months, and disease stabilization going into its fifth month in a patient with triple negative breast cancer. The goal with this treatment is to weaken the drug resistant cancer cells so that they may be sensitized to other treatments as well as become vulnerable to the body's immune system. This is huge. If it's approved by FDA, it will be used with all other cancer drugs to increase their effectiveness. You should get into this, before everyone knows about it and starts to make it's move.
http://finance.yahoo.com/news/vg-life-science...00734.html
http://finance.yahoo.com/news/vg-life-science...00734.html
(0)
(0)
